These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8208055)

  • 1. Disposition and metabolism of Ro 24-4736 in the rat.
    Anastasi EM; Williams TH; Sasso GJ; Chang D; Liberato DJ; Loh AC
    Life Sci; 1994; 54(26):PL483-90. PubMed ID: 8208055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of metabolism and disposition of GDC-0152 in rats using 14C labeling strategy at two different positions: a novel formation of hippuric acid from 4-phenyl-5-amino-1,2,3-thiadiazole.
    Yue Q; Mulder T; Rudewicz PJ; Solon E; Budha N; Ware JA; Lyssikatos J; Hop CE; Wong H; Khojasteh SC
    Drug Metab Dispos; 2013 Feb; 41(2):508-17. PubMed ID: 23223496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and disposition of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate (MOTP) in rats and dogs.
    Kobayashi T; Hohnoki H; Esumi Y; Ohtsuki T; Washino T; Tanayama S
    Xenobiotica; 1988 Jan; 18(1):49-59. PubMed ID: 3354232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of 14C-levamisole in the lactating cow.
    Paulson GD; Feil VJ
    Xenobiotica; 1996 Aug; 26(8):863-75. PubMed ID: 8879150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and disposition of [14C]BMS-690514 after oral administration to rats, rabbits, and dogs.
    Hong H; Su H; Sun H; Allentoff A; Ekhato IV; Chando T; Caceres-Cortes J; Roongta V; Iyer RA; Humphreys WG; Christopher LJ
    Drug Metab Dispos; 2010 Jul; 38(7):1189-201. PubMed ID: 20363952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution, metabolism and excretion of the cholecystokinin-1 antagonist dexloxiglumide in the rat.
    Webber C; Stokes CA; Persiani S; Makovec F; McBurney A; Kapil RP; John BA; Houchen TL; D'Amato M; Chasseaud LF
    Eur J Drug Metab Pharmacokinet; 2003; 28(3):201-12. PubMed ID: 14527093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, metabolism, and disposition of the antiinflammatory 3-[2-(4-methylphenyl)-thioethyl]-sydnone-5-14C in the rat.
    Pirl JN; Bell CL; Lu MC; Bauer L
    Arzneimittelforschung; 1985; 35(3):578-84. PubMed ID: 4039583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and disposition of 14C-granisetron in rat, dog and man after intravenous and oral dosing.
    Clarke SE; Austin NE; Bloomer JC; Haddock RE; Higham FC; Hollis FJ; Nash M; Shardlow PC; Tasker TC; Woods FR
    Xenobiotica; 1994 Nov; 24(11):1119-31. PubMed ID: 7701853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of decabromobiphenyl ether in rats dosed intravenously or by feeding.
    el Dareer SM; Kalin JR; Tillery KF; Hill DL
    J Toxicol Environ Health; 1987; 22(4):405-15. PubMed ID: 3694703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute intravenous and inhalation pharmacokinetics of 2,4-pentanedione in the Fischer 344 rat.
    Frantz SW; Ballantyne B; Leung HW
    Toxicol Ind Health; 1998; 14(3):413-28. PubMed ID: 9569447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of [14C]midazolam in the rat in vitro and in vivo.
    Woo GK; Williams TH; Kolis SJ; Warinsky D; Sasso GJ; Schwartz MA
    Xenobiotica; 1981 Jun; 11(6):373-84. PubMed ID: 7293228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats.
    De Bie AT; Van Ommen B; Bär A
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):150-8. PubMed ID: 9671569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of [14C]brivanib alaninate after oral administration to rats, monkeys, and humans.
    Gong J; Gan J; Caceres-Cortes J; Christopher LJ; Arora V; Masson E; Williams D; Pursley J; Allentoff A; Lago M; Tran SB; Iyer RA
    Drug Metab Dispos; 2011 May; 39(5):891-903. PubMed ID: 21289073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution, metabolism and excretion of 14C-MT-141 in rats. I. Distribution, metabolism and excretion after single intravenous administration in male rats].
    Komiya I; Ishizuka T; Nishio M; Murata S; Esumi Y; Washino T; Matsunaga K; Mitsugi K; Yokoshima T
    Jpn J Antibiot; 1984 May; 37(5):927-37. PubMed ID: 6434764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oral platelet-activating factor antagonist, Ro-24-4736, protects the rat kidney from ischemic injury.
    Kelly KJ; Tolkoff-Rubin NE; Rubin RH; Williams WW; Meehan SM; Meschter CL; Christenson JG; Bonventre JV
    Am J Physiol; 1996 Nov; 271(5 Pt 2):F1061-7. PubMed ID: 8946001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
    Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.